Clinical data by Denkert et al. further support our interpretation which show a significant correlation between CXCL9 mRNA levels and infiltrating T lymphocytes with favorable chemotherapy response in breast cancer patients [14]. The gene discussed is CXCL9; the disease is breast carcinoma.